In an article published early online on July 24, 2008 in the Journal of Cellular Biochemistry, researchers from the University of Medicine and Dentistry New Jersey (UMDNJ) propose a protective role for vitamin D against the development of autoimmune diseases such as multiple sclerosis (MS).
Sylvia Christakos, PhD, and colleagues at the UMDNJ School of Medicine in Newark describe several findings which point to the vitamin’s protective benefit. They observe that the incidence of MS declines as vitamin D from sunlight or diet increases. The disease is mostly unknown in the world’s equatorial regions, where sunlight exposure, and, consequently, vitamin D production in the body, is greatest. Areas of the world in which fish intake is high also have a low incidence of MS. Fish and fish oils are among the few food sources of the vitamin.
It has been suggested that vitamin D assists in regulating immune response. While the hormonally active form of the vitamin has been shown to promote innate immunity, it may have a limiting effect on adaptive immunity. Such autoimmune diseases as allergic encephalitis, lupus erythematosis, autoimmune thyroiditis, arthritis, and autoimmune diabetes have all been shown in laboratory models to be partially prevented by vitamin D.
“Evidence has shown that the maintenance of an adequate vitamin D level may have a protective effect in individuals predisposed to MS,” Dr Christakos stated. “One device of vitamin D action may be to preserve balance in the T-cell reaction and thus avoid autoimmunity.”
In view of the particularly strong reduction in the risk of multiple sclerosis that has been associated with having higher serum levels of 25-hydroxyvitamin D3 before the age of 20, the authors suggest that vitamin D supplements may provide a protective benefit if administered to adolescents and young adults, especially among those with a family history of the disease. The authors write that a large clinical trial of vitamin D or a vitamin D analog is needed to determine whether vitamin D is not only protective, but is helpful as a treatment in individuals with active MS.
In 2004, scientists from the Harvard School of Public Health published the results of two long-term studies on women's health and nutrition. Researchers looked at dietary and supplemental intake of vitamin D as it related to the incidence of MS. Gleaned from the Nurses' Health Study (more than 92,000 women followed from 1980 to 2000) and the Nurses' Health Study II (more than 95,000 women followed from 1991 to 2001), the data support a protective effect for vitamin D against MS, especially for women who consume more than 400 international units (IU) daily of vitamin D from supplements, but not from food sources (Munger KL et al 2004).
In addition to reducing the risk of developing MS, supplemental vitamin D may also provide relief for those actively afflicted with the disease, at least in part by inhibiting nitric oxide, according to animal studies (Garcion E et al 2003). A small clinical trial conducted at the Mayo Clinic was designed to assess the safety and tolerability of daily use for a year of calcitriol, a prescription drug form of vitamin D. Patients who enrolled in the trial were diagnosed with relapsing-remitting MS. Patients received an equivalent of 2.5 micrograms per day (mcg/day) of calcitriol (about 100 IU/day), while their dietary calcium was restricted to 800 milligrams per day (mg/day). Researchers concluded that oral calcitriol is safe and well tolerated by patients with MS who comply with dietary recommendations (Wingerchuk DM et al 2005).
Scientists have also discovered that vitamin D effectively blocks development of MS in animals. When the biologically active, hormone form of vitamin D was administered to animals in a laboratory, the disorder was prevented. Conversely, a deficiency of vitamin D tended to increase the animals' susceptibility to the induced disease. When animals were given vitamin D after developing the disease, progression of symptoms was blocked. When vitamin D supplementation was withdrawn, the disease resumed (Cantorna MT et al 1996, 2000). Numerous laboratories have replicated and expanded upon these findings, prompting one researcher to declare: “Prevention of MS by modifying an important environmental factor (sunlight exposure and vitamin D level) offers a practical and cost-effective way to reduce the burden of the disease in future generations” (Chaudhuri A 2005).
Life Extension members are well aware of the fact that there are many immediately available “promising therapies” for cancer, diabetes, cardiac and other diseases - therapies with lots of scientific research to suggest they could work. However, because the drugs/substances involved are not patentable or have expired patents, no pharmaceutical company will conduct clinical trials to test these treatments. Without clinical trials, physicians often will not prescribe such therapies because the proper dosage/schedules, toxicities and efficacy are not known. So many of these therapies remain in the realm of the ‘unproven’.
GlobalCures (www.global-cures.org), a non-profit medical research institute, was created to address this problem. GlobalCures is ready to test several of the top scientifically promising treatments, but needs to raise funds to do so.
In a grants program called Members Project® (www.membersproject.com), American Express® has asked its card holders for ideas that would positively impact the world. The GlobalCures project has been posted under the title: New, Affordable Treatments with Existing Drugs (Project ID: W7DZSG). In order to be considered for a grant, projects need to have support by the community at large. The twenty-five projects receiving the highest number of votes by September 1, 2008 will proceed to the next phase of the competition. During this current phase, American Express® card holders as well as others can nominate the project.
You hear it almost every day. Be it government health agencies or private organizations, the unanimous directive is for Americans to eat more fruits and vegetables to maintain a healthy lifestyle. Despite constant media publicity, the majority of Americans do not ingest enough fruits and vegetables each day. In fact, a recent Johns Hopkins study found from 1999-2002, only 28% and 32% of American adults met the United States Department of Agriculture (USDA) guidelines for fruit and vegetable intake respectively. Yet scientists are increasingly telling Americans that they must consume these kinds of plants in order to avoid a myriad of age-related problems.
Life Extension Mix™ contains 92 unique vegetable, fruit, herbal extracts, amino acids, vitamins and minerals. This state-of-the-art multinutrient formula has been updated 21 times since its launch in 1983. The Life Extension Mix formula is fortified with botanical extracts that help maintain healthy cells via physiological processes separate from traditional antioxidants.
As people age, systemic inflammation can inflict degenerative effects throughout the body. A primary cause of this destructive cascade is the production of cell-signaling chemicals known as inflammatory cytokines. Along with these dangerous cytokines, imbalances of hormone-like messengers called prostaglandins also contribute to inflammatory processes.
Boswella is composed of boswellic acids, an extract of the resin of the Boswellia serrata tree which grows in India. Boswellic acids are effective at blocking the synthesis of pro-inflammatory 5-lipoxygenase products, including 5-hydroxyeicosatetraenoic acid (5-HETE) and leukotriene B4 (LTB4), which cause bronchoconstriction, chemotaxis, and increased vascular permeability. Boswellic acids may also mediate their inflammatory actions by inhibiting cyclooxygenases, preferentially COX-1.